New York Governor Kathy Hochul has signed a landmark law allowing close friends to authorize organ, eye, or tissue donations for deceased individuals without a next of kin. The legislation, authored by Assemblymember Amy Paulin, aims to bring New York's rules in line with most other states.
Paulin argued that the existing system could result in lost opportunities to save lives simply because those who knew the deceased best were not officially recognized as next of kin. "Close friends often serve as caregivers, decision-makers and are the people who know an individual's values more than anyone else," Paulin said in a statement. This mirrors state law that already grants close friends the power to make important health decisions for patients while they're alive.
The new law comes at a time of heightened controversy within the organ transplantation field, with a recent federal investigation warning New Jersey's organ procurement organization it could be shut down. Additionally, over 8,000 New York residents are currently waiting for an organ transplant, with Black and Latino New Yorkers facing a disproportionately lower rate of transplants compared to white patients.
Paulin argued that the existing system could result in lost opportunities to save lives simply because those who knew the deceased best were not officially recognized as next of kin. "Close friends often serve as caregivers, decision-makers and are the people who know an individual's values more than anyone else," Paulin said in a statement. This mirrors state law that already grants close friends the power to make important health decisions for patients while they're alive.
The new law comes at a time of heightened controversy within the organ transplantation field, with a recent federal investigation warning New Jersey's organ procurement organization it could be shut down. Additionally, over 8,000 New York residents are currently waiting for an organ transplant, with Black and Latino New Yorkers facing a disproportionately lower rate of transplants compared to white patients.